B of A Securities Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $111

B of A Securities analyst Jason Gerberry maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target from $100 to $111.